Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Investment And Acquisition In Rare Diseases

Dec 18 2023

• By Jo Shorthouse

open door with balloons (shutterstock) — • Source: Shutterstock

Related Content

Biogen Buys Time For Leqembi Ramp-Up With Reata Acquisition

Jul 28 2023

Finance Watch: Bausch + Lomb Completes Split From Bausch Health Via IPO

May 06 2022

Deals In 2023: Partnerships And Modest M&A

Feb 06 2023

Vertex Achieves Gene-Editing Milestone With First Ever CRISPR Therapy Approval

Nov 16 2023

Related Companies

Pfizer Inc.

Seagen Inc.

Evox Therapeutics Limited

Rhythm Pharmaceuticals, Inc.

Sanofi Genzyme

Eli Lilly and Company

Alnylam Pharmaceuticals Inc.

Biogen, Inc.

Reata Pharmaceuticals, Inc.

AstraZeneca PLC

Albireo Pharma Inc.

Xinvento BC

Vertex Pharmaceuticals Incorporated

Additional Topics

Rare Diseases M & A Deals Companies Gene Therapy Growth Research & Development BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window